More on the low-profile choice to replace the very high-profile Travis Kalanick – NYTimes and WSJ

Drugmaker Gilead has kickstarted a largely quiet period for big pharma deals with the announcement that it’s acquiring Kite for about $11.9 billion. Kite Pharma’s best known for its emerging cancer treatments that focus on the body’s own immune system to attack malignant cells – NYTimes and WSJ

As it has done whenever it takes on a new field, Amazon is flipping the script for the grocery business as it officially takes the helm of Whole Foods this week – WSJ and Bloomberg

The Supreme Court has agreed to weigh in on the propriety of federal jurisdiction for securities-related class actions under the SLUSA. Defendant Cyan Inc. argues in its opening brief that the act removed state court jurisdiction over these “covered class actions” – Law360

A look at a recent quarter-of-a-billion fine against France’s BNP Paribas over “safety and soundness abuses” for a window into the work of the Fed as a banking regulator – NYTimes

Both parties are unhappy with the world’s largest banks, but there’s some disagreement in the plaintiff ranks between the investors seeking info over alleged forex rate rigging and the DOJ, which is currently seeking a 6-month extension to a discovery stay in the case in order to continue its criminal investigation of the banks’ behavior – Law360

Today’s “what’s old is new again” edition features the return of the in-home salesperson – WSJ

The rise of mail-in DNA kits has led to some surprising discoveries for families around the US. Though understanding the limitations of the tests is as important as celebrating a previously unknown heritage – NYTimes